Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
70 Cards in this Set
- Front
- Back
End diastolic pressure is aka
|
preload
|
|
What is the physical stretching of cardiac muscle that permits optimum overlap of thick and thin filaments and allows the development of tension?
|
preload
|
|
Alteration in developed tension at a set length or set preload
|
contractility
|
|
What is the length-tension curve?
|
Length is on the x axis, tension is on the y axis.
Tells the amount of tension that is developed for a given length/preload. |
|
What does muscle obtained from a failing heart show on the length tension curve?
|
It is shifted down and to the right. That means for a given length (preload), it's not able to generate as much tension.
|
|
the "load" that the heart must eject blood against.
|
afterload
|
|
A(n) (decrease, increase) in afterload decreases the velocity of fiber shortening
|
increase
|
|
The interaction between afterload and preload is utilized in the treatment of heart failure, in which ______ drugs are used to augment stroke volume by decreasing afterload, and at the same time, reduce ventricular preload.
|
vasodilator
|
|
The greater the afterload, the (more, less) the sarcomere shortening
|
Less
|
|
What are the 3 mechanisms by which tension developed by cardiac muscle can be altered?
|
1) Change in preload
2) Change in afterload 3) Change in contractility |
|
What are the 2 main peripheral vascular determinants of cardiac function?
|
1) Venomotor changes that normally alter ventricular loaded end diastolic fiber length
2) Arterial resistance changes that alter left ventricular ejection by regulating aortic impedance. |
|
What is an indirect but accurate measurement of preload?
|
pulmonary capillary wedge pressure.
|
|
Left atrial pressure =
|
pulmonary capillary wedge pressure.
|
|
What types of things reduce preload?
|
diuretic, venodilation, enhancing ejection fraction, increased ventricular stiffness.
They affect the relative or absolute change in intravascular volume. |
|
what is major mechanism in decompensated patient with heart failure to decrease preload?
|
Increase in intravascular volume (leads to edema)
|
|
Two major determinants of afterload
|
1) Systolic pressure
2) Ventricular radius |
|
What are the three major determinants of myocardial oxygen demand?
|
1) myocardial contractility
2) tension development 3) heart rate |
|
What is the MOST major determinant of myocardial oxygen demand?
|
Tension development
|
|
Which uses more energy - isometric or isotonic contraction?
|
Isometric (2-3 times more)
|
|
T/F An increase in afterload results in an increase in myocardial oxygen demand
|
T
|
|
The number one cause of heart failure is ______
|
coronary artery disease (CAD) presenting as ischemic cardiomyopathy.
|
|
What is the Frank-Starling mechanism (or Starling's Law of the heart)?
|
The ability of the heart to change force of contraction in response to changes in venous return.
|
|
(Diastolic, systolic) dysfunction results from a loss of intrinsic inotropy (contractility), most likely due to alterations in signal transduction mechanisms responsible for regulating inotropy.
|
systolic
|
|
What are the two main classes of drugs used to improve heart function in heart failure?
|
Therapeutic interventions to improve cardiac function in heart failure include the use of cardiostimulatory drugs (e.g., beta-agonists and digitalis) that stimulate heart rate and contractility, and vasodilator drugs that reduce ventricular afterload and thereby enhance stroke volume.
|
|
What is the net effect of Neurohumoral responses? (these include activation of sympathetic nerves and the renin-angiotensin system, and increased release of antidiuretic hormone (vasopressin) and atrial natriuretic peptide.)
|
They act to increase blood pressure (arterial and venous) and increase volume.
|
|
How can activation of sympathetic nerves and the renin-angiotensin system, and increased release of antidiuretic hormone (vasopressin) and atrial natriuretic peptide be harmful in heart failure?
|
They act to increase blood pressure (arterial and venous) and increase volume, so they increase afterload and preload to the point that edema may occur.
|
|
Why are beta blockers beneficial in heart failure?
|
they block the effects of excessive sympathetic activation on the heart.
|
|
What is the rational behind using Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and aldosterone receptor antagonists to treat heart failure?
|
They block the RAA system from increasing volume and thus increasing afterload and preload.
|
|
What is the primary method the body uses to compensate for the reduction in cardiac output when heart failure starts?
|
Activation of sympathetic ns. and RAA system in order to <b> increase systemic vascular resistance.</b>
|
|
What mechanisms increase blood volume in order to increase the venous return to the heart in the body's attempt to increase CO via the Frank Starling mech?
|
1) Decreased renal perfusion --> retention of fluid.
2) RAA - contribute to retention of fluid. 3) increase in renal reabsorption of sodium and water |
|
A patient with congestive heart failure can be characterized as having a decrease in CO at the expense of an increase in what?
|
TPR and intravascular volume overload.
|
|
What is the most common cause of CHF in younger patients?
|
Dilated cardiomyopathy.
There are MANY causes for this. |
|
Most common causes of dilated cardiomyopathy in the US.
|
Alcohol
Adriamycin Hypertension Sarcoid Genetic defects |
|
Valvular heart disease that causes CHF in older people is primarily _____ while in younger people is primarily ______.
|
Calcified aortic stenosis; Mitral valve syndrome
|
|
When does the left ventricle "burn out" in corrected congenital heart disease?
|
third or fourth decade
|
|
What is the final common pathway in heart failure?
|
A loss of contractile myocytes and a progressive weakening of the pump. This results in a decrease in cardiac output and stroke volume.
|
|
What does the decrease in cardiac output activate as a "compensatory" mechanism?
|
Called compensatory, but is really pathophysiologic.
Actiates the neurohumoral storm. |
|
Short term regulation of arterial pressure
|
Aorta baroreceptor system; Carotid sinus system ---> Decrease in CO activates <b> sympathetic nervous system</b>
|
|
How is the sympathetic nervous system's reaction to decreased CO pathophysiologic in heart failure?
|
It releases NE which causes
1) Increase in HR 2) Attempt to increase contractility (obviously it can't do too much bc the heart is failing) 3) Increases TPR |
|
T/F In decompensated CHF, circulating NE levels are high
|
T
|
|
What physical findings in decompensated CHF is NE responsible for?
|
Resting tachycardia
Cold, clammy skin Sweating (diaphoresis) |
|
Intermediate-term regulation of arterial pressure
|
Renin-Angiotensin system.
Decreased CO --> Decreased Renal blood flow ---> Renin release --> AI converted to A2 by ACE --> Volume retention |
|
How does Angiotensin II affect the brain?
|
It drives thirst response in hypothalamus.
Patients with CHF are always thirsty. Stimulates posterior pituitary to release ADH. |
|
What is beta natriuretic peptide?
|
polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells
|
|
When is beta natriuretic peptide released and what does it do?
|
Released when the heart is volume overloaded (ie., in CHF).
Attempts to cause systemic and pulmonary arterial vasodilation and salt-wasting. Unfortunately it is overwhelmed by the actions of angiotensin II and other neurohormones. |
|
Since beta natriuretic peptide doesn't actually cause a natriuresis or diuresis in heart failure, what is it useful for?
|
Diagnosis. Presence of this in the presence of volume overload strongly suggests heart failure.
|
|
What is left ventricular afterload reduction?
|
It's using pharmacology to decrease TPR and inhibit the neurohormonal storm, thus decreasing afterload and increasing CO in heart failure.
It's been the guiding light in development of successful treatment for CHF. |
|
_________ is a cofactor for fibrosis formation
|
Aldosterone. It promotes fibrosis in the myocardium!
|
|
What is the mechanism of sudden death in advanced heart failure?
|
Increased wall tension, stretching of the conduction system ---> VT ---> VF --> death
|
|
How is the overuse of diuretics related to sudden death in heart disease?
|
Diuretics cause hypokalemia and hypomagnesemia.
This promotes arrhythmia generation. Ventricular fibrillation rapidly leads to death. |
|
Chief complaints in CHF
|
Fatigue, shortness of breath, dyspnea on exertion
|
|
PE findings in CHF
|
Resting tachycardia
Narrow pulse pressure. JVP distension Enlarged liver Lateral displacement of apical impulse |
|
What is cause of narrow pulse pressure in CHF?
|
Increased sympathetic drive with decreased CO
|
|
What are ECG findings in CHF?
|
Sinus tach; evidence of old MI (possibly); LV hypertrophy (with htn); right or left bundle branch blocks
|
|
What are CXR findings in CHF?
|
Cardiomegaly with pulmonary venous htn and LA and LV enlargement
|
|
What is the best/most essential dx test in CHF?
|
echocardiogram.
Quantitates the degree of LV dysfunction, chamber size, chamber enlargement, chamber volumes, and regurgitant lesions. |
|
What is the cause of the “pseudodesert” or “pseudohemorrage” in CHF that leads to the reduction in arterial pressure?
|
Reduced stroke volume and cardiac output.
|
|
Persistently positive plasma troponin - what does it mean?
|
It's a poor prognostic sign.
It means that there is calcium load and apoptotic programs have been increased. |
|
What hormone causes myocyte hypertrophy and apoptosis?
|
Angiotensin II
|
|
Increasing atrial stretch thru volume overload can cause what?
|
Atrial arrhythmias/atrial fibrillation.
|
|
What kind of prognostic sign is persistently elevated endogenous natriuretic peptides?
|
failure to normalize natriuretic peptide plasma levels a poor prognostic sign
|
|
What synergistic factors predispose to life-threatening arrhythmias in CHF?
|
1) Arrhythmogenic substrates: infarcts, areas of fibrosis; slowed conduction; favor reentrant arrhythmias
2) Sympathetic stimulation 3) Ischemia 4) Increased wall tension/stretch 5) Iatrogenic factors: hypokalemia, hypomagnesemia |
|
What is treatment/prevention for life-threatening arrhythmias in CHF?
|
Automatic implantable cardiac defibrillator (AICD)
Drug therapy usually not effective, limited by proarrhythmia Amiodarone of some use, inferior to AICD |
|
How can the neurohumoral storm be blocked?
|
Pharmacologically.
Give vasodilators to patients with borderline hypotension. This reduces afterload. Negative inotropes (beta blockers) work to decrease arrhythmias, ischemia, persistent cell death. |
|
How do negative inotropes (eg, beta blockers) work in CHF?
|
They reduce one component of the neurohormonal storm (sympathetic NE stimulation).
Thus, they decrease arrhythmias, ischemia, persistent cell death. Over time they improve mortality. |
|
Elevated left atrial/pulmonary capillary wedge pressure cause what symptoms?
|
Pulmonary edema symptoms - orthopnea, dyspnea, paroxysmal nocturnal dyspnea
|
|
Elevated left atrial/pulmonary capillary wedge pressure cause what signs?
|
Rales
|
|
Elevated right atrial pressure causes what symptoms?
|
Symptoms:
Hepatic congestion: nausea, vomiting GI congestion: nausea, bloating Swelling Dyspnea due to pleural effusions |
|
Elevated right atrial pressure causes what signs?
|
Elevated jugular venous pressure, peripheral edema, “pulsatile” liver edge, hepatojugular reflux
|
|
Low forward CO causes what symptoms?
|
Fatigue, lightheadedness, orthostatic symptoms
|